Iranian Journal of Pediatrics

Published by: Kowsar

BLES Versus Curosurf for Treatment of Respiratory Distress in Preterm Neonates and Their Adverse Effects

Zeinab Kheradmand Sarokolai 1 , * , Pedram Niknafs 1 , Farhad Azizzadeh 1 , Bahareh Bahman Bijari 1 and Hamid Mousavi 1
Authors Information
1 Department of Pediatrics, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Iranian Journal of Pediatrics: August 2018, 28 (4); e11734
  • Published Online: June 2, 2018
  • Article Type: Research Article
  • Received: April 13, 2017
  • Revised: November 19, 2017
  • Accepted: March 4, 2018
  • DOI: 10.5812/ijp.11734

To Cite: Kheradmand Sarokolai Z, Niknafs P, Azizzadeh F, Bahman Bijari B, Mousavi H. et al. BLES Versus Curosurf for Treatment of Respiratory Distress in Preterm Neonates and Their Adverse Effects, Iran J Pediatr. 2018 ;28(4):e11734. doi: 10.5812/ijp.11734.

Abstract
Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Martin RJ, Fanaroff AA, Walch MC. Neonatal Perinatal Medicine. 10th ed. USA: Jennifer A Wambach, Aaron Hamvas; 2015. p. 1074-83.
  • 2. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443-56. doi: 10.1542/peds.2009-2959. [PubMed: 20732945]. [PubMed Central: PMC2982806].
  • 3. Anadkat JS, Kuzniewicz MW, Chaudhari BP, Cole FS, Hamvas A. Increased risk for respiratory distress among white, male, late preterm and term infants. J Perinatol. 2012;32(10):780-5. doi: 10.1038/jp.2011.191. [PubMed: 22222548]. [PubMed Central: PMC3461404].
  • 4. Cloherty JP, Eichenwald EC, Stark AS. Manual of Neonatal Care. 6th ed. USA: Kushal Y Bhatka; 2008. p. 323-30.
  • 5. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2001;(2). CD000144. doi: 10.1002/14651858.CD000144. [PubMed: 11405951].
  • 6. Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11. CD001456. doi: 10.1002/14651858.CD001456.pub2. [PubMed: 23152207].
  • 7. Halliday HL. Surfactants: past, present and future. J Perinatol. 2008;28 Suppl 1:S47-56. doi: 10.1038/jp.2008.50. [PubMed: 18446178].
  • 8. Lam BC, Ng YK, Wong KY. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome. Pediatr Pulmonol. 2005;39(1):64-9. doi: 10.1002/ppul.20125. [PubMed: 15558604].
  • 9. Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American Study G. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21(3):109-19. doi: 10.1055/s-2004-823779. [PubMed: 15085492].
  • 10. Downes JJ, Vidyasagar D, Boggs TJ, Morrow G3. Respiratory distress syndrome of newborn infants. I. New clinical scoring system (RDS score) with acid--base and blood-gas correlations. Clin Pediatr (Phila). 1970;9(6):325-31. doi: 10.1177/000992287000900607. [PubMed: 5419441].
  • 11. Ortiz RM, Cilley RE, Bartlett RH. Extracorporeal membrane oxygenation in pediatric respiratory failure. Pediatr Clin North Am. 1987;34(1):39-46. doi: 10.1016/S0031-3955(16)36179-X. [PubMed: 3808772].
  • 12. Saeidi R, Hamedi A, Javadi A. Comparison of side effect of Survanta and Curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem hospital on 2006-2008. Iran J Neonatol. 2013;4(3):7-12. doi: 10.22038/ijn.2013.1747.
  • 13. Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;(7). CD003935. doi: 10.1002/14651858.CD003935.pub4. [PubMed: 26142898].
  • 14. Lopez-Suarez O, Garcia-Magan C, Saborido-Fiano R, Perez-Munuzuri A, Bana-Souto A, Couce-Pico ML. [Ante-natal corticosteroids and prevention of respiratory distress in the premature newborn: usefulness of rescue treatment]. An Pediatr (Barc). 2014;81(2):120-4. doi: 10.1016/j.anpedi.2013.06.028. [PubMed: 24113118].
  • 15. Smrcek JM, Schwartau N, Kohl M, Berg C, Geipel A, Krapp M, et al. Antenatal corticosteroid therapy in premature infants. Arch Gynecol Obstet. 2005;271(1):26-32. doi: 10.1007/s00404-004-0664-4. [PubMed: 15309401].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments